These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 38477744

  • 1. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
    Qiu S, Dhaliwal R, Divine G, Warner E, Rao SD.
    J Bone Miner Res; 2024 May 02; 39(4):417-424. PubMed ID: 38477744
    [Abstract] [Full Text] [Related]

  • 2. Bone Structure and Turnover Status in Postmenopausal Women with Atypical Femur Fracture After Prolonged Bisphosphonate Therapy.
    Qiu S, Divine GW, Palnitkar S, Kulkarni P, Guthrie TS, Honasoge M, Rao SD.
    Calcif Tissue Int; 2017 Mar 02; 100(3):235-243. PubMed ID: 28013363
    [Abstract] [Full Text] [Related]

  • 3. Bone Nanomechanical Properties and Relationship to Bone Turnover and Architecture in Patients With Atypical Femur Fractures: A Prospective Nested Case-Control Study.
    Griffin LV, Warner E, Palnitkar S, Qiu S, Honasoge M, Griffin SG, Divine G, Rao SD.
    JBMR Plus; 2021 Sep 02; 5(9):e10523. PubMed ID: 34532612
    [Abstract] [Full Text] [Related]

  • 4. Changes in cortical width with bone turnover in the three different endosteal envelopes of the ilium in postmenopausal osteoporosis.
    Tanizawa T, Itoh A, Uchiyama T, Zhang L, Yamamoto N.
    Bone; 1999 Oct 02; 25(4):493-9. PubMed ID: 10511118
    [Abstract] [Full Text] [Related]

  • 5. Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-Term Bisphosphonate Users with Atypical Femur Fracture.
    Farlay D, Rizzo S, Ste-Marie LG, Michou L, Morin SN, Qiu S, Chavassieux P, Chapurlat RD, Rao SD, Brown JP, Boivin G.
    J Bone Miner Res; 2021 Jun 02; 36(6):1031-1041. PubMed ID: 33434290
    [Abstract] [Full Text] [Related]

  • 6. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH, Myong JP, Yoo J, Lim YW, Lee J, Kwok SK, Park SH, Ju JH.
    Osteoporos Int; 2017 Nov 02; 28(11):3251-3259. PubMed ID: 28748389
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
    Miller PD, McCarthy EF.
    Semin Arthritis Rheum; 2015 Apr 02; 44(5):477-482. PubMed ID: 25312241
    [Abstract] [Full Text] [Related]

  • 8. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
    Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y.
    J Bone Miner Metab; 2015 Sep 02; 33(5):553-9. PubMed ID: 25227287
    [Abstract] [Full Text] [Related]

  • 9. Bone Formation Parameters of the Biopsied Ilium Differ between Subtrochanteric and Diaphyseal Atypical Femoral Fractures in Bisphosphonate-Treated Patients.
    Kondo N, Fukuhara T, Watanabe Y, Miyasaka D, Yamamoto N, Sato H, Wada Y, Nakatsue T, Fujisawa J, Sakuma M, Imai N, Yoda T, Narita I, Endo N.
    Tohoku J Exp Med; 2017 Dec 02; 243(4):247-254. PubMed ID: 29212985
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy.
    Franceschetti P, Bondanelli M, Caruso G, Ambrosio MR, Lorusso V, Zatelli MC, Massari L, Degli Uberti EC.
    Bone; 2013 Oct 02; 56(2):426-31. PubMed ID: 23871850
    [Abstract] [Full Text] [Related]

  • 11. Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis.
    Dempster DW, Zhou H, Rao SD, Recknor C, Miller PD, Leder BZ, Annett M, Ominsky MS, Mitlak BH.
    J Bone Miner Res; 2021 Apr 02; 36(4):644-653. PubMed ID: 33434314
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review.
    Bauer DC, Black DM, Dell R, Fan B, Smith CD, Ernst MT, Jurik AG, Frøkjær JB, Boesen M, Vittinghoff E, Abrahamsen B.
    J Clin Endocrinol Metab; 2024 Oct 15; 109(11):e2141-e2150. PubMed ID: 38198798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates.
    Watts NB, Aggers D, McCarthy EF, Savage T, Martinez S, Patterson R, Carrithers E, Miller PD.
    J Bone Miner Res; 2017 May 15; 32(5):1027-1033. PubMed ID: 28071822
    [Abstract] [Full Text] [Related]

  • 15. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
    Lee SH, Lee YH, Suh JS.
    AJR Am J Roentgenol; 2017 Oct 15; 209(4):867-873. PubMed ID: 28796551
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Lim SJ, Yeo I, Yoon PW, Yoo JJ, Rhyu KH, Han SB, Lee WS, Song JH, Min BW, Park YS.
    Osteoporos Int; 2018 Nov 15; 29(11):2427-2435. PubMed ID: 30039251
    [Abstract] [Full Text] [Related]

  • 19. Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users.
    Chou AC, Ng AC, Png MA, Chua DT, Ng DC, Howe TS, Koh JS.
    Bone; 2015 Oct 15; 79():170-5. PubMed ID: 26067179
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.